SCHEMBL3662758

SCHEMBL3662758

COC(=O)c1cc(I)cc(N)c1F.COC(=O)c1cc(I)cc([N+](=O)[O-])c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT6 Q8N6T7 1/20 0.39
CFTR P13569 3/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
PDGFRA P16234 1/20 0.39
FLT1 P17948 1/20 0.39
FGFR3 P22607 1/20 0.39
KDR P35968 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
GAA P10253 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
GLA P06280 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
ATM Q13315 1/20 0.35
SOS1 Q07889 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357183 0.92 SIRT6 (0.44) SIRT6PDGFRBFGFR1PDGFRAFLT1
SCHEMBL358224 0.86 CFTR (0.49) CFTRKDM4EALDH1A1GAAHSD17B10
SCHEMBL28723015 0.81 ALDH1A1 (0.45) SIRT6CFTRPDGFRBFGFR1PDGFRA
SCHEMBL5221908 0.78 ALDH1A1 (0.43) CFTRTDP1KDM4EALDH1A1GAA
SCHEMBL913705 0.78 PDGFRB (0.46) SIRT6PDGFRBFGFR1PDGFRAFLT1
SCHEMBL5219938 0.76 ALDH1A1 (0.46) SIRT6PDGFRBFGFR1PDGFRAFLT1
SCHEMBL2522809 0.76 PDGFRB (0.50) SIRT6PDGFRBFGFR1PDGFRAFLT1
SCHEMBL2901232 0.75 TDP1 (0.47) SIRT6PDGFRBFGFR1PDGFRAFLT1
SCHEMBL1462927 0.75 TDP1 (0.47) SIRT6PDGFRBFGFR1PDGFRAFLT1
SCHEMBL670584 0.75 PDGFRB (0.47) SIRT6CFTRPDGFRBFGFR1PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234989-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077371-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed